Liquid Biopsy Summit
(Lisbon, February 20, 2020)

Presentation „Liquid biopsies: Coming of age of promising tools“

Cancer Precision Medicine Forum
(Berlin, December 2, 2019)

Panel discussion: „Examining the influence of current regulatory & policy frameworks in facilitating the progress & implementation of Precision Oncology“

2nd Annual Companion Diagnostics & Biomarker Conference
(Porto, February 14, 2019)

Panel discussion: „Regulation of CDx in the EU“

Biotech Pharma Summit 2017
(Porto, October 26, 2017)

Presentation: „Case Study Companion Diagnostics“

Nordic Precision Medicine Forum
(Copenhagen, April 26, 2017)

Presentation: „Companion Diagnostics – recent advantages and future perspectives”

Pharma Danmark Conference
(Copenhagen, November 5, 2016)

Presentation: „Personalized Medicine – recent advantages and future perspectives”

Medtech & Pharma Platform „Inovative drug-device combinations and diagnostics“
(Basel, September 22-23, 2016)

Presentation: „Companion diagnostics development – current status & future perspective“”

Precision Medicine Congress
(London, September 12-13, 2016)

Panel Discussion: „Advancing Precision Medicine, including NGS, in the Evolving Regulatory Environment”

World CDx Conference
(London, March 15-17, 2016)

Workshop: Drug-Companion Diagnostic Adoption & Reimbursement: „A Comprehensive Guide to the Major European States“

Panel Discussion: „How do we Deal with the Ever-Changing Regulatory Landscape?”

Precision Medicine Congress
(London, September 14-15, 2015)

Panel discussion: „Future of Precision Medicine“

World CDx Conference
(Berlin, March 17-19, 2015)

Workshop: “Operational Management of a CDx program: A comprehensive guide to the major regulatory landscapes“

SBA Academy „Changing paradigms in drug development“
(Bern, February 3, 2015)

Presentation: „Personalized medicine – changing the way drugs are developed and used“

Precision Medicine Congress
(London, May 19-20, 2014)

Panel discussion: “Choosing & Managing RxDx partnerships“

CHI Web Training Course „Use of Companion Diagnostics for Driving Precision Medicine in CNS Disorders“
(April 10, 2014)

Presentation: „CDx Regulatory Framework: Lessons Learned From Oncology“

BioM m4 Strategy Workshop
(Munich, March 19-20, 2014)

Presentation: “Personalised Medicine – a new paradigm in healthcare“

ADAPT Congress Global Strategies for Companion Diagnostics
(Boston, November 4–5, 2013)

Presentation: “The Economic Value within Companion Diagnostics and Stratified Medicines Relationships”

Sachs Annual Biotech in Europe Investor Forum
(Zurich, September 30–0ct. 1, 2013)

Panel Discussion: “Personalised Medicine and Companion Diagnostics: from development to market”

Oncotest Symposium
(Freiburg, April 25–16, 2013)

Presentation: “Overcoming practical hurdles related to the operationalization of Personalized Medicine clinical trials”

Sachs European Lifescience CEO Forum
(Zurich, March 5–6, 2013)

Presentation: “Regenerative medicine – on the cutting edge of healthcare and personalised medicine”

M4 Biomarker Conference
(Munich, November 22–23, 2012)

Panel Discussion: “Molecular imaging for personalized medicine: a doubtful future?“


Ich bin persönlich für Sie da
Martina Kaufmann, PhD
Managing Director

Tel.: +49 7631 748652
Mobil: +49 160 96765716